Welcome to our dedicated page for Leveljump Health news (Ticker: JMPHF), a resource for investors and traders seeking the latest updates and insights on Leveljump Health stock.
LevelJump Healthcare Corp. (JMPHF), also listed on the TSX Venture Exchange as JUMP, is a healthcare diagnostics company focused on radiology and telehealth. Its news flow centers on developments in its Teleradiology division, which provides telehealth solutions to client hospitals and imaging centers, and its Diagnostic Centres, which deliver in-person radiology services. The company states that it concentrates on critical care for urgent and emergency patients, so many updates relate to how its imaging services support high-acuity clinical settings.
Investors following LevelJump’s news can expect regular financial results releases, where the company reports revenues, net income or loss, and EBITDA, including contributions from its 100% owned subsidiary, Canadian Teleradiology Services, Inc. These updates often discuss year-over-year growth in diagnostic imaging volumes and clinic operations. News items also cover acquisition activity, such as agreements to acquire diagnostic imaging outpatient clinics and independent healthcare facilities in Alberta, along with commentary on how these transactions are intended to expand the company’s diagnostic services footprint.
LevelJump’s disclosures further include corporate and regulatory updates, such as the issuance and revocation of a Failure-to-File Cease Trade Order, applications for reinstatement of trading on the TSX Venture Exchange, and information on working capital and banking discussions. Governance and shareholder matters, including annual meeting results and a shareholder requisition seeking changes to the board of directors, are also reported through company news releases.
By monitoring this news page, readers can review a chronological archive of LevelJump Healthcare announcements, covering financial performance, clinic acquisitions, trading status, and shareholder developments related to JMPHF and its TSXV listing JUMP.
LevelJump Healthcare (JMPHF) closed a non-brokered private placement effective April 16, 2026, issuing 14,380,000 common shares at C$0.05 per share for gross proceeds of C$719,000.
Securities are subject to a 4-month plus one day hold ending August 17, 2026, and the offering has conditional TSX Venture Exchange acceptance pending final approval. The company paid C$10,150 in finder fees and issued 203,000 non-transferable finder’s warrants exercisable at C$0.05 for two years. Net proceeds will be used for general working capital. Offered shares were placed with arm's length parties and are not registered for U.S. sale.
LevelJump Healthcare (OTC: JMPHF) intends a non-brokered private placement of up to 15,000,000 common shares at $0.05 per share to raise up to $750,000, subject to TSX Venture Exchange approval.
The Offering is expected to close on or around April 16, 2026, carries a four-month-plus-one-day hold, may include insider participation, and aims to fund general working capital. Finder's fees up to 7% cash and 7% in warrants may be payable.
LevelJump Healthcare Corp (OTC: JMPHF) granted 2,250,000 incentive stock options to three directors under its 2022 Equity Incentive Plan. Each option allows purchase of one common share at an exercise price of $0.065 until February 24, 2031. There are no vesting restrictions.
LevelJump Healthcare (OTC Pink: JMPHF) announced a cooperation agreement with shareholder Frank Teti that immediately reconstitutes the board to add independent perspectives. Effective January 20, 2026, Dr. Sheldon Levy, Rob Saltsman, and Sean Aylward were appointed to the board, with Mr. Aylward named chair. In conjunction with these appointments, Gary Prihar, Richard Jagodnik, and Jackie Glazer resigned.
As part of the agreement, Mr. Teti withdrew a prior requisition for a special shareholder meeting and agreed to support the company’s updated director slate at the next annual meeting.
LevelJump Healthcare (JMPHF) announced its board has scheduled an annual and special shareholder meeting for May 26, 2026 in response to a shareholder requisition by Frank Teti and Franmar Properties requesting removal of all directors and appointment of five new directors.
The Board said it combined the annual and requisitioned special meeting because audited financial statements will be available by that date and to avoid the cost of holding two meetings in close succession, noting a prior shareholder meeting was held in September 2025. A management circular and voting instructions will be mailed to shareholders of record in advance; shareholders are not required to act now.
LevelJump (OTC: JMPHF) reported Q3 2025 results for the three and nine months ended September 30, 2025. Q3 revenue was $4.84M, up 8.7% year‑over‑year, and nine‑month revenue was $14.1M, up 9.1% year‑over‑year. The company reported a Q3 net loss of $(26,378) and nine‑month net income of $5,754. Consolidated Q3 EBITDA was $600,677 and nine‑month EBITDA was $1.90M. The 100% owned subsidiary Canadian Teleradiology Services generated Q3 EBITDA $836,000 and nine‑month EBITDA $3.04M. A previously announced acquisition of two Calgary clinics was terminated after landlord approval was not obtained. Management cited organic clinic growth and service expansion plans in Alberta.
LevelJump Healthcare Corp (JMPHF) received a notice of requisition on November 3, 2025 requesting a shareholders' meeting under section 105(1) of the Business Corporations Act (Ontario).
The Requisition, submitted by Frank Teti and Franmar Properties Ltd., seeks to: (i) remove all five incumbent directors and (ii) elect five named nominees — Claude Ayache, Rob Saltsman, Jeff Stevens, Sheldon Levy, and Tasheel Jeerh. The company said it is reviewing the Requisition and will respond within the time required by the Act.
LevelJump Healthcare (OTC: JMPHF) announced trading on the TSX Venture Exchange is expected to resume on or about October 9, 2025. The company says 12 months of disclosure including an annual information form are available on SEDAR+ and its website.
Key corporate updates include director re-elections at the September 4, 2025 AGM, Exchange acceptance notices for existing management consulting agreements, and insider loans totaling an aggregate requested maximum of $1,900,000 (with $65,288 advanced against the additional $309,457 request). The company filed interim June 30, 2025 financials showing a $2,637,203 working capital deficiency and canceled a planned purchase of its leased headquarters.
LevelJump Healthcare (TSXV: JUMP) has released its Q2 2025 financial results, showing consistent growth in revenues and operational performance. The company reported Q2 2025 revenues of $4.7 million, up 6.2% from the previous year, and six-month revenues of $9.3 million, representing a 9.4% increase year-over-year.
The company's subsidiary, Canadian Teleradiology Services, achieved an EBITDA of $1.01 million in Q2 and $2.23 million for the six-month period. Additionally, LevelJump is proceeding with its previously announced acquisition of two diagnostic imaging clinics in Calgary, with the transaction expected to close by October 2025.
LevelJump Healthcare (TSXV: JUMP) has announced that the Ontario Securities Commission (OSC) has revoked its Failure-to-File Cease Trade Order (FFCTO) that was issued on May 7, 2025. The company has now met all continuous disclosure obligations under securities legislation and is actively seeking reinstatement of trading on the TSX Venture Exchange.
The company will issue a news release before trading resumes.